Drug Shortage Report for TEVA-TELMISARTAN

Last updated on 2019-04-11 History
Report ID 67219
Drug Identification Number 02320177
Brand name TEVA-TELMISARTAN
Common or Proper name TELMISARTAN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TELMISARTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-20
Estimated end date 2019-03-30
Actual end date 2019-03-30
Shortage status Resolved
Updated date 2019-04-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-04-11 French Compare
v6 2019-04-11 English Compare
v5 2019-03-12 French Compare
v4 2019-03-12 English Compare
v3 2018-11-21 English Compare
v2 2018-11-20 French Compare
v1 2018-11-20 English Compare